Collective Wisdom: Lobular Carcinoma of the Breast.

Breast cancer researchers have a longstanding fascination for infiltrating lobular carcinomas. Second in frequency only to ductal adenocarcinomas, these tumors are characterized by unique histopathology and (among breast cancers) distinctive clinical biology, both in the primary and metastatic settings. Early hints regarding the underlying sources of this peculiar cancer, in particular the important role of E-cadherin loss, have now been confirmed through comprehensive molecular portraits of the disease. These molecular observations, in turn, go far to explain how lobular carcinomas play out in the clinic, both as regards local control and therapeutic response to systemic therapy. Together, the “collective wisdom” of the laboratory and the clinic paint an interesting portrait of this fascinating disease.

[1]  D. Dodwell,et al.  Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary. , 2016, Clinical radiology.

[2]  A. Giobbie-Hurder,et al.  Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  V. Tjan-Heijnen,et al.  Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer , 2015, Annals of Surgical Oncology.

[4]  M. Lautrup,et al.  Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: A single-centre study of 1575 consecutive cases. , 2014, Breast.

[5]  A. Turnbull,et al.  Molecular changes in lobular breast cancers in response to endocrine therapy. , 2014, Cancer research.

[6]  T. King,et al.  Magnetic resonance imaging in patients with newly diagnosed breast cancer: A review of the literature , 2014, Cancer.

[7]  D. Dabbs,et al.  Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response. , 2014, Cancer research.

[8]  P. Fasching,et al.  Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma , 2014, Breast Cancer Research and Treatment.

[9]  R. Turner,et al.  Preoperative Magnetic Resonance Imaging in Breast Cancer: Meta-Analysis of Surgical Outcomes , 2013, Annals of surgery.

[10]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[11]  H. Putter,et al.  Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis. , 2013, European journal of cancer.

[12]  D. Berry,et al.  Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer , 2012, Breast Cancer Research and Treatment.

[13]  J. Carroll,et al.  Pioneer factors in hormone-dependent cancers , 2012, Nature Reviews Cancer.

[14]  L. Costarelli,et al.  Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period , 2012, Annals of Surgical Oncology.

[15]  T. Major,et al.  Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-Year results. , 2011, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[16]  J. Dixon,et al.  Invasive lobular carcinoma: response to neoadjuvant letrozole therapy , 2011, Breast Cancer Research and Treatment.

[17]  M. Beckmann,et al.  Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. , 2011, International journal of radiation oncology, biology, physics.

[18]  D. Young,et al.  Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma , 2009, World journal of surgical oncology.

[19]  Ritse M. Mann,et al.  MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature , 2007, Breast Cancer Research and Treatment.

[20]  Michael Gnant,et al.  Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF , 2007, Breast Cancer Research and Treatment.

[21]  P. Chérel,et al.  Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  P. Regitnig,et al.  The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma , 2006, Journal of Clinical Pathology.

[23]  S. Harms,et al.  Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. , 2005, American journal of surgery.

[24]  A. R.,et al.  Review of literature , 1960, American Potato Journal.

[25]  H. Carmalt,et al.  Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. , 2004, Breast.

[26]  P. Bult,et al.  The Role of MRI in Invasive Lobular Carcinoma , 2004, Breast Cancer Research and Treatment.

[27]  R. Rouzier,et al.  The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. , 2004, European journal of cancer.

[28]  P. Blondeel,et al.  Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[29]  P. Drew,et al.  Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  T. Lioe,et al.  Surgical treatment for invasive lobular carcinoma of the breast. , 2003, Breast.

[31]  P. Drew,et al.  Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast , 2003 .

[32]  M. Wadley,et al.  The diagnosis of invasive lobular breast carcinoma. Does MRI have a role? , 2001, Breast.

[33]  J. Imbrie,et al.  Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. , 2000, Annals of surgery.